Beyond the Hype: How Data and AI-Driven Insights Are Shaping Investment Decisions in Pharma

Session details:

AI is reshaping the pharmaceutical landscape, but how can BD&L professionals move from hype to practical value? This session will explore real-world applications of data - and AI-driven insights in BD&L strategy, focusing on key challenges such as assessing deal quality, predicting asset success, optimizing portfolio decisions, and evaluating the competitive landscape. Attendees will further their knowledge on identifying early-stage, high-potential investments more confidently with the right combination of data, AI, and solution partner.